|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
Q4 FY2025
As of Jan 31, 2025
|
Q3 FY2025
As of Oct 31, 2024
|
Q2 FY2025
As of Jul 31, 2024
|
Q1 FY2025
As of Apr 30, 2024
|
Q4 FY2024
As of Jan 31, 2024
|
Q3 FY2024
As of Oct 31, 2023
|
Q2 FY2024
As of Jul 31, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents, current | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net of allowance of $0 and $3, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Capitalized internal-use software, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Restricted cash and cash equivalents, non-current | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Liability from early exercise of stock options | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Public and private placement warrant liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Deferred hosting costs | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Convertible notes | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at July 31, 2026 and January 31, 2026, 340,163,832 and 312,421,506 Class A shares issued and outstanding at July 31, 2026 and January 31, 2026, respectively, 21,157,586 Class B shares issued and outstanding at July 31, 2026 and January 31, 2026, 0 Class C shares issued and outstanding at July 31, 2026 and January 31, 2026 | ||||||||||||||||||||
| Total common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at July 31, 2026 and January 31, 2026, 340,163,832 and 312,421,506 Class A shares issued and outstanding at July 31, 2026 and January 31, 2026, respectively, 21,157,586 Class B shares issued and outstanding at July 31, 2026 and January 31, 2026, 0 Class C shares issued and outstanding at July 31, 2026 and January 31, 2026 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...